Most new investors won't touch a penny stock and w

Quote:

---

Most new investors won't touch a penny stock and will likely think that the Leronlimab story is too good to be true and won't think twice about it.

---

Not to mention that typing Cytodyn in google will bring up results for investors hub well before investors hangout. So even if they do run across investors hangout the well has already been poisoned. Trial results in well designed trials is what will change perceptions.